PROVIDER PROFILE · NPI 1588727093

Wendy Stock

PRACTICEMEDCENTRIX INCSee all providers at this practice →

Hematology-OncologyChicago, ILI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

159

Unique beneficiaries

—

Total services

426

Distinct HCPCS

Medicare payment

$37K

Peer benchmark

Total Medicare services vs. 444 Hematology-Oncology providers in IL — bottom quintile (cohort median 1,266).

PRESCRIBING · PART D · 2024

Total Rx claims

189

Beneficiaries

—

Total drug cost

$2.4M

Distinct drugs

Brand share

82.5%

Top prescribed drugs

Ponatinib Hcl55 claims

Venetoclax48 claims

Acalabrutinib Maleate24 claims

Acyclovir20 claims

Nilotinib Hcl18 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$5K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$3K

Consulting Fee$2K

Food and Beverage$219

REFERRAL NETWORK

Where Wendy Stock's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MACMAHON, HEBER	16	156
Sandeep Gurbuxani Pathology · Chicago, IL	13	126
WANG, YUE-LYNN	13	98
Richard Larson Hematology-Oncology · Chicago, IL	12	372
ZISKIND, LAUREN	11	421

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history